Colorectal Cancer screening in ambulatory healthcare service clinics in Abu Dhabi, United Arab Emirates in 2015–2016

Almansoori, Aysha; Alzaabi, Mariam; AlKetbi, Latifa Mohammad Baynouna

doi:10.1186/s12885-021-08623-9

Cited by 8 publications

(6 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, the national program from the MOH showed results similar to those of other screening programs in Kuwait and Qatar [ 34 , 35 ]. Similarly, the retrospective studies were consistent with those of other studies conducted in the UAE, Bahrain, and Oman [ 36 , 37 , 38 ]. Among Gulf countries, only Qatar and the UAE have national screening programs [ 39 ], and the next-generation sequencing method of screening is still underused in Saudi Arabia, despite multiple studies on its cost and time effectiveness [ 40 , 41 ].…”

Section: Discussionsupporting

confidence: 89%

Screening, awareness and challenges for colorectal cancer treatment in Saudi Arabia: an update

Hassan Alqarni,

Alamri,

Pushparaj

et al. 2024

Bioinformation

View full text Add to dashboard Cite

Colorectal cancer (CRC) is the second most common cancer in the world. In Saudi Arabia, CRC is the most common cancer in males and the third most common in females, and its incidence rate is rising as the country continues to develop. However, the country does not have a national CRC screening program for CRC. This review aims to review recent studies that have attempted to address and rectify this issue and discern the most notable and prevalent barriers. Despite these efforts, guidelines are still lacking. Two prospective studies have been conducted in recent years, one of which was a national pilot screening program conducted by the Ministry of Health (MOH). While both had a similar number of participants, the colonoscopy rate for patients with a positive fecal immunochemical test (FIT) in the MOH program was only 20% compared to 75.8% in the Al-Kharj program. Awareness of the Saudi population regarding CRC and its screening appears to be insufficient. The most common barriers to patients' willingness to undergo screening were embarrassment, fear, and pain. Barriers to physicians are mostly related to factors outside their hands, such as lack of equipment and time. We conclude that efforts should be made to establish a national screening program and improve awareness of the population and physicians.

show abstract

Section: Discussionsupporting

confidence: 89%

Screening, awareness and challenges for colorectal cancer treatment in Saudi Arabia: an update

Hassan Alqarni,

Alamri,

Pushparaj

et al. 2024

Bioinformation

View full text Add to dashboard Cite

show abstract

“…The detection rates of polyps and CRC vary by country or region. For example, Almansoori et al reported that polyps were found in 30.5% of confirmed cases in Dubai, of whom 0.2% had CRC [16]. Other studies include rates of 67% and 7% in Ireland [17], 55.3% and 3.7% in Canada [18], 47.3% and 0.9% in Singapore [19], and 32.2% and 1.6% in Guangzhou, China [2].…”

Section: Discussionmentioning

confidence: 99%

Effects of Fecal Occult Blood Immunoassay Screening for Colorectal Cancer—Experience from a Hospital in Central Taiwan

Yang

Chiang

et al. 2023

Medicina

View full text Add to dashboard Cite

Background and Objectives: In 2004, the Health Administration of Taiwan began to promote a hospital-based cancer screening quality improvement program, under the principle that “prevention is better than therapy”. The aim of this study was to evaluate the effectiveness of colorectal cancer (CRC) screening in patients who received a fecal immunochemical test (FIT) at a hospital in central Taiwan. Materials and Methods: This was a retrospective study. Results: Fecal occult blood immunoassays for CRC screening were conducted in 58,891 participants, of whom 6533 were positive (positive detection rate 11.10%). The positive patients then underwent colonoscopy, and the detection rates of polyps and CRC accounted for 53.6% and 2.4% of all colonoscopy-confirmed diagnoses (3607), respectively. We further enrolled data from patients diagnosed with CRC at our hospital from 2010 to 2018. The patients with CRC were divided into two groups according to whether or not they had received fecal occult blood screening. Among the 88 patients with CRC by screening, 54 had detailed medical records including cancer stage. Of these 54 patients, 1 (1.8%) had pre-stage, 11 (20.4%) had stage I, 24 (44.4%) had stage II, 10 (18.5%) had stage III, and 8 (14.8%) had stage IV CRC. The early cancer detection rates of the screening and non-screening groups were 66.7% and 52.7%, respectively, and the difference was significant (p = 0.00130). Conclusions: In this study, screening with FIT significantly increased the early detection of CRC. The main advantage of FIT is the non-invasiveness and low cost. It is hoped that the further adoption of early screening can increase the detection rates of colorectal polyps or early cancer to improve survival, reduce the high cost of subsequent cancer treatment, and reduce the burden on the patient and healthcare system.

show abstract

“…There are several local screening programs for each region, as outlined in Table 4 [ 10 , 11 , 12 , 13 , 14 ]. Unfortunately, no official published data are available on cancer screening uptake, but unofficial reports estimate that breast and colorectal cancer screening is used by no more than 25% of the eligible population [ 15 ]. Instead of the current opportunistic screening approach, there is a need for a UAE-wide national screening program that covers breast, colorectal, cervical, lung, and prostate cancer and includes a call-and-recall system [ 13 , 16 , 17 ].…”

Section: Cancer Screening Programs In the Uaementioning

confidence: 99%

“…Hence, currently, most of the cancer care expenditure is for non-citizens. Social barriers to cancer screening must be addressed systematically [ 15 , 19 , 20 , 21 ]. The utilization of approved blood-based cancer screening (e.g., Epi proColon) can be considered as an option that may be less invasive and has potential higher uptake for cancer screening [ 22 ].…”

Section: Cancer Screening Programs In the Uaementioning

confidence: 99%

The State of Cancer Care in the United Arab Emirates in 2022

Al-Shamsi

2022

Clinics and Practice

View full text Add to dashboard Cite

Cancer is the third-leading cause of death in the United Arab Emirates (UAE); cancer care in the UAE has evolved dramatically over the last 40 years, from a single center in Al Ain in 1981 to more than 30 cancer centers and clinics across the UAE, with at least four comprehensive cancer centers in the UAE nowadays. Despite the significant progress in medical care, cancer quality control across the UAE is still lacking, with significant variations in cancer care across the cancer centers. Access to clinical trials is still hampered by a lack of expertise and research infrastructure and a small population, which renders patient accrual for trials a major challenge. Education and training are other areas for improvement that require immediate attention, and, in this review, we try to address these critical aspects for stakeholders to consider better cancer care in the UAE. Early cancer detection and screening are still evolving in the UAE, and a national screening program is lacking. There is also a need to address barriers to screening and to consider less invasive screening methods such as approved blood-based screening, which is likely to be more acceptable to the UAE population. In this review, we also address new topics that have not been addressed previously, including oncology medical tourism, psycho-oncology, onco-fertility, precision oncology, survivorship, oncology nursing, cancer support programs, and the oncology sector’s response to the COVID-19 pandemic, all in the context of the UAE cancer landscape. Finally, we provide recommendations for policymakers, regulators, payers, patient advocacy groups, and the UAE oncology community regarding the delivery and future planning of high-quality cancer care. These recommendations are aligned with the UAE government’s vision to reduce cancer mortality and provide high-quality healthcare for its citizens and residents.

show abstract

Colorectal Cancer screening in ambulatory healthcare service clinics in Abu Dhabi, United Arab Emirates in 2015–2016

Cited by 8 publications

References 22 publications

Screening, awareness and challenges for colorectal cancer treatment in Saudi Arabia: an update

Screening, awareness and challenges for colorectal cancer treatment in Saudi Arabia: an update

Effects of Fecal Occult Blood Immunoassay Screening for Colorectal Cancer—Experience from a Hospital in Central Taiwan

The State of Cancer Care in the United Arab Emirates in 2022

Contact Info

Product

Resources

About